European Centre for Disease Prevention and Control. Healthcare- associated infections acquired in intensive care units. In: ECDC. Annual epidemiological report for 2017. Stockholm: ECDC; 2019.
Rosa L, Cutone A, Coletti M, et al. Biotimer assay: A reliable and rapid method for the evaluation of central venous catheter microbial colonization. J Microbiol Methods 2017; 143: 20-5.
Ielapi N, Nicoletti E, Lorè C. et al.The Role of Biofilm in Central Venous Catheter Related Bloodstream Infections: Evidence-based Nursing and Review of the Literature. Rev Recent Clin Trials. 2020;15(1):22-27. doi: 10.2174/1574887114666191018144739. PMID: 31656155.
Gominet M, Compain F, Beloin C, Lebeaux D. Central venous catheters and biofilms: where do we stand in 2017? APMIS. 2017 Apr;125(4):365- 375. doi: 10.1111/apm.12665. PMID: 28407421.
Özdemir K., Dizbay M. Nosocomial infection and risk factors in elderly patients in intensive care units / K. Özdemir, M. Dizbay // Journal of Microbiology and Infectious Diseases. 2015. Vol. 1. P. 38-43.
Burnham JP, Rojek RP, Kollef MH. Catheter removal and outcomes of multidrug-resistant central-line-associated bloodstream infection. Medicine (Baltimore). 2018 Oct;97(42):e12782. doi: 10.1097/MD.0000000000012782. PMID: 30334966; PMCID: PMC6211864.
WHO. Report on the burden of endemic health care-associated infection Worldwide, 2011. URL: http://apps.who.int/iris/bitstream/10665/80135/1/ 9789241501507_eng.pdf
Baier C, Linke L, Eder M. et al. Incidence, risk factors and healthcare costs of central line-associated nosocomial bloodstream infections in hematologic and oncologic patients. PLoS One. 2020 Jan 24;15(1):e0227772. doi: 10.1371/journal.pone.0227772. PMID: 1978169; PMCID: PMC6980604.
Özalp Gerçeker G, Yardımcı F, Aydınok Y. Central Line-Associated Bloodstream Infections in Children With Hematologic and Oncologic Diseases: First Prevalence Results From a University Hospital. J Pediatr Oncol Nurs. 2019 Sep/Oct;36(5):327-336. doi: 10.1177/1043454219844226. Epub 2019 Apr 26. PMID: 31027430.
Timsit JF, Rupp M, Bouza E. et al.A state of the art review on optimal practices to prevent, recognize, and manage complications associated with intravascular devices in the critically ill. Intensive Care Med. 2018 Jun;44(6):742-759. doi: 10.1007/s00134-018-5212-y. Epub 2018 May 12. PMID: 29754308.
van der Kooi T, Sax H, Pittet D, van Dissel J. et al. PROHIBIT consortium. Prevention of hospital infections by intervention and training (PROHIBIT): results of a pan-European cluster-randomized multicentre study to reduce central venous catheter-related bloodstream infections. Intensive Care Med. 2018 Jan;44(1):48-60. doi: 10.1007/s00134-017- 5007-6. Epub 2017 Dec 16. PMID: 29248964.
Naomi P. O'Grady et al. Guidelines for the Prevention of Intravascular Catheter-Related Infections, 2011. URL: https://www.cdc.gov/hai/pdfs/bsi-guidelines-2011.pdf
Ling, M.L., Apisarnthanarak, A., Jaggi, N. et al. APSIC guide for prevention of Central Line Associated Bloodstream Infections (CLABSI). Antimicrob Resist Infect Control 5, 16 (2016). https://doi.org/10.1186/s13756-016-0116-5
Infusion Therapy Standards of Practice. The Official Publication of the Infusion Nurses Society. //Journal of Infusion Nursing.8th Edition Revised 2021 January/February 2021. Vol.44, Number 1S. 169P
Infusion Therapy Standards of Practice. The Official Publication of the Infusion Nurses Society. //Journal of Infusion Nursing. January/February 2016. Vol.39, Number 1S. 169P.
Guidelines HIV Prevention, diagnosis, treatment and care for key populations. //WHO. July 2014. 184C.
Infusion Nurses Society; Policies and Procedures for Infusion Nusing. J.Infus.Nurs.2016.
Christofer J.Crnich fnd Denis G.Maki. The promise of Novel Technology for the Prevention of Intravascular Device-Related Bloodstream Infection. II. Long-Term Devices.//J. Healthcare Epidemiology March 2016. 1362-1368. CID 2002:34